C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 471/10 (2006.01) A61K 31/438 (2006.01) A61P 3/00 (2006.01)
Patent
CA 2760340
Compounds of formula (I) as well as pharmaceutically acceptable salts thereof can be used in the form of pharmaceutical compositions, wherein n, m, A, R1 and R2 have the significance given in claim 1. The compounds are useful as HSL inhibitors for the treatment of diabetes dyslipidemia, atherosclerosis and obesity.
La présente invention a pour objet des composés de formule (I) ainsi que des sels pharmaceutiquement acceptables de ceux-ci pouvant être utilisés sous la forme de compositions pharmaceutiques, n, m, A, R1 et R2 ayant la signification donnée dans la revendication 1. Les composés sont utiles en tant qu'inhibiteurs de la HSL pour le traitement du diabète, de la dyslipidémie, de l'athérosclérose et de l'obésité.
Ackermann Jean
Conte Aurelia
Hunziker Daniel
Neidhart Werner
Nettekoven Matthias
F.hoffmann-La Roche Ag
Gowling Lafleur Henderson Llp
LandOfFree
Azacyclic spiroderivatives as hsl inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Azacyclic spiroderivatives as hsl inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Azacyclic spiroderivatives as hsl inhibitors will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1400416